FDA Investigator Lisa L Flores

Lisa L Flores has conducted inspections on 171 sites in 9 countries as of 18 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
171
Last Inspection Date:
18 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Netherlands, Sweden, Italy, Greece, Germany, China, India, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Lisa L Flores:
Abdollah Koolivand, Adree N Anderson, Adrienne Morgan, Akbar J Zaidi, Alan E Mehl, Alan L Truong, Alan M Barker, Alesya V Oleynik, Alysia C Alger, Amy E Devine, Amy L Mccarthy, Andrew A Hoopes, Andrew K Schaal, Angela E Glenn, Anna L Tucker, Annemarie Kleiza, Anthony J Ladner, Anthony R Bucks, April K Hill, Ashlee M Ward, Ashley A Mutawakkil, Audra J Ashmore, Barbara I Rogolsky, Barbara Janine Breithaupt, Benjamin J Smith, Bo Chi, PhD, Brandi E Williams, Brant M Schroeder, Brent M Dehaan, Brent T Hall, Brett R Havranek, Brian R Cronenwett, Brittany D Terhar, Brooke K Higgins, Brooke K Seeman, Bruce E Taylor, Burnell M Henry, Candace S Tucker, Carl A Huffman, III, Catherine R Olguin, Ceisha C Ukatu, Chad W Rice, Charles L Zhou, Charles O'brein, Chilton L Ng, Chris A Sack, Christopher D Snyder, Christopher S Keating, Christopher T Middendorf, Christopher T Peters, Cody D Rickman, Cody J Alley, Colleen Thomas, PhD, Collins M Mason, Constantin Y Philopoulos, Courtney E Hillier, Cynthia M Goudeau, Dana D Carter, SR DDS, Danial S Hutchison, Daniel J Roberts, Darrah, David A Place, David J Eide, David J Leray, David L Miser, David M Beltran, David P King, Dawn C Olenjack, Deidre R Edwards, Dell S Moller, Diana K Krepel, Diana M Guidry, Diane L Raccasi, Doan T Nguyen, PharmD, Douglas A Campbell, Dwight D Ferguson, Edward E Lockwood (EEL), Emest F Bizjak, Emilie E Kahn, Eric C Nielsen, Eric M Mueller, PharmD, Eric M Padgett, Eric T Huebler, Erika V Butler, Erin C Dugan, Esther A Ofori, Ewa Marszal, PhD, Farhana Khan, Fred K Kelly, Frederick F Razzaghi, Geneve M Maxwell, Geneve M Parks, Gloria J Champagne, Gretchen Lf Trendel, Guo Q Shen, Gwyn G Dickinson, Hala L Selby, Heath W Cartwright, Helen B Ricalde, Hiwot A Kesi, Howard A Burmester, Howard Anderson, PhD, Huffmanc, Ingrid Y Johnson, J Michael Cannon, PhD, Jacob G Lutz, James I Giefer, James J Houlihan, James P Mcreavey, Janet A Rajan, Janet L Bowen, Janete A Eaker, Janete A Oliveira, Janna C Hutchinson, Jazmine N Still, Jeffery A Hangartner, Jeffery L Sumter, Jeffrey A Sommers, Jeffrey B Moody, Jeffrey D Meng, Jessica E Hensley, Jessica L Peterson, Jill J Tillman, Jimmie L Weigand, John A Iwen, John E Emmert, Johnson, Jonathan R Campos, Joohi Castelvetere, Jose Acruz Gonzalez, Joseph R Lambert, Joshua S Hunt, Julie V Bailey, Kamara Mo, Kara L Roden, Karen C Daugherty, Karen M Kondas, Karen M Montgomery (KMM), Katherine M Taylor, Kathleen B Swat, Kathleen J Close, Kellia N Hicks, Kenneth H Williams, Kevin A Beavers, Kham Phommachanh, Kimberlee A Ewing, Kristi B Panzer, Kristi M Hampton Thurston, L Grant, Lakshmi Narasimhan, PhD, Lareese K Thomas, Larry K Austin, Lauren N Smith, LCDR Audra J Lenhart, LCDR Ismael Olvera, IV, LCDR Matthew J Morrison, Liming Zhang, Linda K Cline, Linhart, Lisa L Gilliam, Lisa W Flores, Logan T Williams, Lori A Gioia, Lorie S Hannappel, Louis S Chen, Lucas B Leake, Luella J Rossi, Marcellinus D Dordunoo, Marcus F Yambot, Maria Gutierrez Lugo, PhD, Marion D Wimberly, Jr, Mark G Peterson, Massoud Motamed, Matthew B Casale, Matthew H Hunt, Matthew M Schuckmann, Megan T Ziegler, Meisha R Sampson, Meisha Waters, Melinda L Rice, Melissa J Garcia, Melissa N Simanton, Michael A Feingold, Michael C Zubelewicz, Michael D Porter, Michael G Truchan, Michael L Casner, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Michelle C Webb, Mindy M Chou, Minerva Rogers, Miranda D Mcdonald, Monica E Murie, Monica M Mcclure, Mra Davism, Muna Algharibeh, Nadeem I Chaudhry, Nadine Nanko Johnson, Nancy G Schmidt, Nancy P Hamburg, Neal L Adams, Nia K Walker, Nicole C Mayfield, Norman K Starks, Omotunde O Osunsanmi, Pamela L Velez Vega, Pamela N Agaba, Parul M Patel, Patrick L Wisor, Peter E Gruman, Philip J Boston, Pratik S Upadhyay, DDC, Qin Xu, Rafeeq A Habeeb, Ralph A Erickson, Ramon A Hernandez, Rashonda N Rucker, Rebecca E Dombrowski, Regina T Brown, Rendall E Barfoot, Richard D Coleman, Rita K Kabaso, Robert J Ham, Robert J Nesselhauf, Robert M Barbosa, Robert T Lorenz, Robin K Reel, Rochelle L Cross, Rodney D Combs, Rohn R Robertson, Rosanna M Goodrich, Rumany C Penn, PharmD, Russell J Glapion, Ryan S Martin, Saleem A Akhtar, Samuel K Gibbons, Jr, Sandra A Boyd, Scott A Golladay, Scott A Jepson, Scott T Ballard, Shafiq S Ahadi, Shanna R Haden, Sharon K Thoma, PharmD, Shaun M Olson, Shaun M Stracener, Sherry G Bous, Shirley J Berryman, Sina Shojaee, Sondra L Phillips, Steven D Kehoe, Steven E Bowen, PhD, Steven P Allen, Steven P Donald, Stroman, Susan D Yuscius, Susanna E Ford, Tamara J Umscheid, Tara G Bizjak, Tara L Breckenridge, Tara L Greene, Tara L King, Tara M Aikens, Tara M Humfeld, Ted L Anderson, Teresa S Johnson, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tiffani D Wilson, Tomika L Bivens, Tonya R Johnson, Torrey M Ward, Toyin B Oladimeji, Tristian E Strait, Vaishali J Patel, Vanessa J Stefka, Veronica Fuentes, MS, Vickie J Kanion, Victoria A Wagoner, Walsworth, Warren J Lopicka, Wayne D Mcgrath, Weston K Szymanski, William C Corley, William F Lagud, Jr, Zachary A Bogorad, Zhenzhen Liu, PhD

Lisa L Flores's Documents

Publish Date Document Type Title
July, 2023 FDA 483 Northland Nuclear Medicine, LLC - Form 483, 2023-07-13
May, 2023 FDA 483 Megafine Pharma (P) Limited - Form 483, 2023-05-12
April, 2022 FDA 483 Response Weeks & Leo Co., Inc. - Form 483R, 2022-04-27
March, 2018 FDA 483 Response Weeks & Leo Co., Inc. - Form 483R, 2018-04-19
April, 2015 EIR ADM Animal Nutrition - EIR, 2015-04-02
July, 2022 FDA 483 Apotheca Company - Form 483, 2022-07-14
September, 2021 FDA 483 Response GSK Consumer Health, Inc. - Form 483R, 2021-10-21
December, 2022 FDA 483 TriRx Shawnee LLC - Form 483, 2022-12-14
September, 2019 FDA 483 Kerry, Inc. - Form 483, 2019-09-12
November, 2019 FDA 483 Virbac Corporation - Form 483, 2019-11-25
September, 2021 FDA 483 GSK Consumer Health, Inc. - Form 483, 2021-09-30
January, 2020 EIR Alcami Carolinas Corporation - EIR, 2020-01-16
July, 2021 FDA 483 Apotheca Company - Form 483, 2021-07-14
April, 2023 FDA 483 BioLyte Laboratories, LLC - Form 483, 2023-04-27
April, 2022 EIR Weeks & Leo Co., Inc. - EIR, 2022-04-07
October, 2021 FDA 483 Aire-Master of America, Inc. - Form 483, 2021-10-19
July, 2023 FDA 483 A-OX WELDING SUPPLY CO., INC. - Form 483, 2023-07-17
March, 2023 FDA 483 Rechon Life Science AB - Form 483, 2023-03-17
April, 2022 FDA 483 Weeks & Leo Co., Inc. - Form 483, 2022-04-07
March, 2022 FDA 483 Response Nova-Tech, Inc. - Form 483R, 2022-03-15
March, 2018 EIR Weeks & Leo Co., Inc. - EIR, 2018-03-29
May, 2022 FDA 483 Cambrex Charles City, Inc. - Form 483, 2022-05-02
August, 2023 FDA 483 Curium US LLC - Form 483, 2023-08-18
March, 2018 FDA 483 Weeks & Leo Co., Inc. - Form 483, 2018-03-29
January, 2018 FDA 483 Hiland Dairy Foods Company, LLC - Form 483, 2018-01-04
November, 2021 FDA 483 Mobren Transport Inc. - Form 483, 2021-11-18
February, 2022 FDA 483 Hot Shots NM, LLC - Form 483, 2022-02-18
August, 2021 FDA 483 HNC Products Inc. - Form 483, 2021-08-24
May, 2022 FDA 483 Zoetis LLC - Form 483, 2022-05-23
December, 2023 FDA 483 Exelead, Inc. - Form 483, 2023-12-20
October, 2022 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2022-10-20
January, 2023 FDA 483 GPT Pharmaceuticals Private Limited - Form 483, 2023-01-27
March, 2022 FDA 483 Nova-Tech, Inc. - Form 483, 2022-03-15
February, 2024 FDA 483 SSM Health Care St. Louis DBA SSM St. Clare Health Center - Form 483, 2024-02-08
March, 2024 FDA 483 LUPIN LIMITED - Form 483, 2024-03-15
August, 2024 FDA 483 Baxter Healthcare Corporation - Form 483, 2024-08-01
September, 2024 FDA 483 Staska Pharmaceuticals, Inc. - Form 483, 2024-09-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more